Search Results 441-450 of 13971 for anti-TNF drugs

  1. Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis - Mayo Clinic

    Non-steroidal anti-inflammatory drugs (NSAIDs), Cyclooxygenase (COX)-2 inhibitors, or aspirin >100 mg/day within 2 weeks prior to Screen 2; TNF-alpha ...

  2. Monoclonal antibody treatment can help high-risk patients with COVID-19 - Mayo Clinic News Network

    The Food and Drug Administration (FDA) issued an emergency use authorization to use bamlanivimab and casirivimab-imdevimab to treat confirmed COVID-19 in ...

  3. A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD) - Mayo Clinic

    corticosteroids, immunomodulators (eg, AZA, 6-mercaptopurine, methotrexate), and/or TNF-α antagonist therapy (e.g., infliximab, adalimumab). This includes ...

  4. Pentoxifylline (oral route) - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

  5. Statins for the Treatment of NASH - Mayo Clinic

    Immune modulatory agents including systemic steroids, methotrexate, anti-TNF-? therapies (infliximab, adalimumab, etanercept) or anti-integrin therapy

  6. Mayo Clinic Minute: What's the skinny on weight-loss drugs?

    Now, Mayo Clinic experts say there is a new tool to help in the battle against obesity, a prescription medication that can curb your appetite. And a recent ...

  7. Enzalutamide (oral route) - Mayo Clinic

    Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for ...

  8. A Study to Evaluate the Safety, Effectiveness and Microbiological Response of Orally Administered ABI-M201 in Subjects with Mildly-to-Moderately Active Ulcerative Colitis with Ongoing Mesalamine Treatment - Mayo Clinic

    To evaluate a new oral treatment, ABI-M201 (or placebo) in individuals with mild to moderate Ulcerative Colitis who have sustained an inadequate response to ...

  9. Ibalizumab-uiyk (intravenous route) - Mayo Clinic

    ... anti-HIV medicines that did not work well, who are resistant to many antiretroviral medicines, or who are failing their current antiretroviral treatment.

  10. Antidepressants: Can they stop working? - Mayo Clinic

    Underlying health problems, such as hypothyroidism, can cause or worsen depression. A new medication. Some medications for unrelated conditions can interfere ...